OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects
Mariam Farrag, Djedjiga Ait Eldjoudi, María González‐Rodriguez, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Relationship of asprosin and diabetes: a meta-analysis
Xiandong Zeng, Xin Sun, Wei He, et al.
BMC Endocrine Disorders (2025) Vol. 25, Iss. 1
Open Access

Molecular identification of asprosin and its function on glucose and lipid metabolism in grass carp (Ctenopharyngodon idella)
Guokun Yang, Mingyue Yin, Hao Wang, et al.
Aquaculture (2025), pp. 742221-742221
Closed Access

Predictive roles of Asprosin and Gremlin-1 expression in Egyptian pediatric patients with type 1 diabetes
Al‐Shimaa M. Abas, Marwa M. Esawy, Fatma Kamel, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Investigation of the Effect of Asprosin Level on Fertility Success and Oxidative Stress in Simmental Cows
Rukiye Köse, Serkan Ali Akarsu, Serdal Kurt, et al.
Reproduction in Domestic Animals (2025) Vol. 60, Iss. 2
Open Access

Serum Asprosin Correlates with Indirect Insulin Resistance Indices
Małgorzata Mirr, Anna Braszak-Cymerman, Aleksandra Ludziejewska, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1568-1568
Open Access | Times Cited: 13

Asprosin: its function as a novel endocrine factor in metabolic-related diseases
Yang Zhang, Ping Yang, Xinliang Zhang, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 8, pp. 1839-1850
Closed Access | Times Cited: 3

A study of the relationship between serum asprosin levels and MAFLD in a population undergoing physical examination
Dan Lv, Zepu Wang, Cuiqiao Meng, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3

Adipokines and their role in acute pancreatitis
Saira Rafaqat, Irena Radoman-Vujačić, Dimitrios Patoulias, et al.
Journal of Medical Biochemistry (2024) Vol. 43, Iss. 4, pp. 512-527
Open Access | Times Cited: 2

Asprosin promotes vascular inflammation via TLR4-NFκB-mediated NLRP3 inflammasome activation in hypertension
Rui Ge, Jun-Liu Chen, Fen Zheng, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e31659-e31659
Open Access | Times Cited: 2

Adipokines in pregnancy
Monika Dawid, Karolina Pich, Ewa Mlyczyńska, et al.
Advances in clinical chemistry (2024), pp. 172-269
Closed Access | Times Cited: 1

Lack of correlation between asprosin serum levels and hyperphagic behavior in subjects with prader-Willi Syndrome
Maria Felicia Faienza, Mariangela Chiarito, Alessia Aureli, et al.
Journal of Endocrinological Investigation (2024)
Closed Access | Times Cited: 1

Effect of Boric Acid on Metabolic Peptides and Some Biochemical Parameters in Experimental Diabetic Rats
Selcen ÇAKIR
Biological Trace Element Research (2023)
Closed Access | Times Cited: 3

The role of serum asprosin levels in predicting the severity of coronary artery disease in patients with diabetes mellitus
Ismail Yıgıtdol, Erdinç Gülümsek, Derya Demirtaş, et al.
Irish Journal of Medical Science (1971 -) (2024) Vol. 193, Iss. 3, pp. 1239-1247
Closed Access

Asprosin contributes to pathogenesis of obesity by adipocyte mitophagy induction to inhibit white adipose browning in mice
Sheng Chen, Wanwan Yuan, Qianqian Huang, et al.
International Journal of Obesity (2024) Vol. 48, Iss. 7, pp. 913-922
Closed Access

New insights of acylation stimulating protein in modulating the pathological progression of metabolic syndromes
Lian Xi, Ye Cheng, Hui-Yuan Kang
International Immunopharmacology (2024) Vol. 132, pp. 112018-112018
Closed Access

Research Progress of Proinflammatory Adipokines and Type 2 Diabetic Nephropathy
丽萍 高
Journal of Clinical Personalized Medicine (2024) Vol. 03, Iss. 02, pp. 308-314
Open Access

Effects of atypical antipsychotics on serum asprosin level and other metabolic parameters in patients with schizophrenia
Kiumarth Amini, Mohammad‐Javad Motallebi, Kimia Bakhtiari, et al.
Human Psychopharmacology Clinical and Experimental (2024) Vol. 39, Iss. 5
Closed Access

Examining the Potential Applicability of Orexigenic and Anorexigenic Peptides in Veterinary Medicine for the Management of Obesity in Companion Animals
Cezary Osiak-Wicha, Katarzyna Kras, Ewa Tomaszewska, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 6725-6745
Open Access

Asprosin: the potential player in combined double diabetes and hypothyroidism
Hussein Jawad Hassan, Ekhlas Khalid Hameed, Taghreed Uloom Mohammad
Irish Journal of Medical Science (1971 -) (2024)
Closed Access

Eugenol alleviates the negative effects of experimental periodontitis and regulates adipokine hormones in rats
Sema Nur Sevinç Gül, Didem Özkal Eminoğlu, Emre Tekçe, et al.
South African Journal of Botany (2024) Vol. 172, pp. 579-585
Closed Access

Development of a Mix-and-Read Assay for Human Asprosin using Antibody-Oligonucleotide Probes and Thermofluorimetric Analysis
Juan Hu, Christopher J. Easley
Analytical Methods (2024) Vol. 16, Iss. 35, pp. 6057-6063
Closed Access

Asprosin in nonalcoholic fatty liver disease and hypothyroidism: a case-control study
Mona Abdel-Latif Aboul-Seoud, Mohamed Kamal Ghitany, Ola Atef Sharaki, et al.
Alexandria Journal of Medicine (2024) Vol. 60, Iss. 1, pp. 265-273
Open Access

Page 1 - Next Page

Scroll to top